The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Borodulina E.V.

Samara State Medical University, Ministry of Health of Russia, Samara, Russia

Suslin S.A.

Samara State Medical University, Ministry of Health of Russia, Samara, Russia

Organization of tuberculosis detection in Russia and worldwide

Authors:

Borodulina E.V., Suslin S.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2018;21(4): 87‑92

Read: 4653 times


To cite this article:

Borodulina EV, Suslin SA. Organization of tuberculosis detection in Russia and worldwide. Russian Journal of Preventive Medicine. 2018;21(4):87‑92. (In Russ.)
https://doi.org/10.17116/profmed201821487

Recommended articles:
Challenges, problems and approaches to healthcare digi­tal technologies enha­ncement. Russian Journal of Preventive Medi­cine. 2024;(12):31-36
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Is arti­ficial inte­lligence nece­ssary for healthcare system?. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):40-48
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84

References:

  1. Moscow Ministerial Declaration «End TB». Accessed March 28, 2018 (In Russ.)
  2. Mordyk AV, Puzyreva LV, Aksyutina LP. Modern international and national concepts of fight against tuberculosis. Dal’nevostochnyj zhurnal infekcionnoj patologii. 2013;22:92-97. (In Russ.)
  3. Borodulina EA. Screening of TB infection. State of the problem. Jepidemiologija i vaktsinoprofilaktika. 2016;15(1):28-33. (In Russ.)
  4. Mohireva LV, Skachkov VV, Veretentseva NA, Kolpakova LV. Organization of work with groups of risk for tuberculosis in medical organizations of primary health care. Tuberkulez i social’no znachimye zabolevanija. 2015;1:32-35. (In Russ.)
  5. Tuberculosis in the Russian Federation, 2012/2013/2014. Analytical review of statistical indicators used in the Russian Federation and in the world. Moscow; 2015.] (In Russ.)
  6. Doug Campos-Outcalt. Screening for tuberculosis: Updated recommendations. Journal of Family Practice. 2017;66(12):755-757.
  7. Global Tuberculosis Report 2016. World Health Organization. 2016;214.
  8. Rating of countries in the world in terms of expenditure on health. [Humanitarian Encyclopedia. Center for Humanitarian Technologies, 2006-2018. Accessed March 28, 2018.] (In Russ.) http://gtmarket.ru/ratings/expenditure-on-health/info
  9. Kundu D, Sharma N, Chadha S, Laokri S, Awungafac G, Jiang L, Asaria M. Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India. Health Economics Review. 2018;8(1):3. https://doi.org/10.1186/s13561-018-0187-5
  10. Shelby PW, Lia MP, Israel A. Collaborative public-private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012—2016. Journal of Healthcare Leadership. 2017;9:47-57. https://doi.org/10.2147/jhl.s130207
  11. Ananthakrishnan R, Jacob AG, Das M, Isaakidis P, Kumar AMV. Intensified tuberculosis case finding amongst vulnerable communities in southern India. Public Health Action. 2015;5(4):246-248. https://doi.org/10.5588/pha.15.0048
  12. Mhimbira FA, Cuevas LE, Dacombe R, Mkopi A, Sinclair D. Interventions to increase tuberculosis case detection at primary healthcare or community-level services. Cochrane Database System Review. 2017;11:CD011432. https://doi.org/10.1002/14651858.cd011432
  13. Yellappa V, Lefèvre P, Battaglioli T, Devadasan N, Van der Stuyft P. Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district. BMC Public Health Journal. 2017;17(1):635. https://doi.org/10.1186/s12889-017-4627-7
  14. Yellapa V, Devadasan N, Krumeich A, Pant Pai N, Vadnais C, Pai M, Engel N. How patients navigate the diagnostic ecosystem in a fragmented health system: a qualitative study from India. Global Health Action. 2017;10(1): 1350452. https://doi.org/10.1080/16549716.2017.1350452
  15. Ade S, Affolabi D, Adjobimey M, Ade G, Anagonou S, Kumar AMV, Harries A. Operational research within the national tuberculosis control programme in Benin. BMC Research Notes. 2017;10(1):651. https://doi.org/10.1186/s13104-017-2987-9
  16. Datta B, Hazarika A, Shewade HD, Ayyagari K, Kumar AM. Digital chest X-ray through a mobile van: public private partnership to detect sputum negative pulmonary TB. BMC Research Notes. 2017;10(1):96. https://doi.org/10.1186/s13104-017-2420-4
  17. Nagaraja SB, Satyanarayana S, Shastri S. Active tuberculosis case finding in India: need for introspection. Public Health Action. 2017;7(4):307. https://doi.org/10.5588/pha.17.0074
  18. Alshamsan R, Lee J, Rana S, Areabi H, Millett C. Comparative health system performance in six middle-income countries: cross-sectional analysis using. World Health Organization study of global ageing and health. Journal of the Royal Society of Medicine. 2017;110(9):365-375. https://doi.org/10.1177/0141076817724599
  19. Goudge J, Alaba OA, Govender V, Harris B, Nxumalo N, Chersich M. Social health insurance contributes to universal coverage in South Africa, but generates inequities: survey among members of a government employee insurance scheme. International Journal for Equity in Health. 2018;17(1):1. https://doi.org/10.1186/s12939-017-0710-z
  20. GBD Tuberculosis Collaborators The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. The Lancet. 2017;18(3):261-284. https://doi.org/10.1016/S1473-3099(17)30703-X
  21. Amaral L, Molnar J. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent «as new use». Recent Pat Antiinfect Drug Discovery. 2010;5(2):109-114. https://doi.org/10.2174/157489110791233540
  22. Shah N, Auld S, Brust J, Mathema B, et al. Transmission of extensively drug-resistant tuberculosis in South Africa. The New England Journal of Medicine. 2017;376(3):243-253. https://doi.org/10.1056/NEJMoa1604544
  23. Cox HS, McDermid C, Azevedo V, et al. Epidemic levels of drug resistant tuberculosis (MDR and XDR TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One. 2010;5(11):13901. https://doi.org/10.1371/journal.pone.0013901
  24. Schmidt BM, Geldenhuys H, Tameris M, et al. Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community. South African Medical Journal. 2017;107(12):1078-1081. https://doi.org/10.7196/SAMJ.2017.v107i12.12502
  25. Chikaonda T, Nguluwe N, Barnett B, Gokhale R, Krysiak R, Thengolose I. Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi. African Journal of Laboratory Medicine. 2017;6(2):464. https://doi.org/10.4102/ajlm.v6i2.464
  26. Kerrigan D, West N, Tudor C, Hanrahan CF, et al. Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research. Health Res Policy Syst. 2017;15(1):42. https://doi.org/10.1186/s12961-017-0206-8
  27. Li X, Yang Y, Liu J, Zhou F, Cui W, Guan L, Shen F, Gao C. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a metaanalysis. Frontiers in Medicine. 2013;7(3):354-366. https://doi.org/10.1007/s11684-013-0257-3
  28. Wu Y, Zhang L, Liu X, Ye T, Wang Y. Geographic variation in health insurance benefits in Qianjiang District, China: a cross-sectional study. International Journal for Equity in Health. 2018;17(1):20. https://doi.org/10.1186/s12939-018-0730-3
  29. Xie B, Huo M, Wang Z, Chen Y, Fu R, Liu M, Meng Q. Impact of the New Cooperative Medical Scheme on the trend of catastrophic health expenditure in Chinese rural households: results from nationally representative surveys from 2003 to 2013. BMJ Open. 2018;8(2):e019442. https://doi.org/10.1136/bmjopen-2017-019442
  30. Li J, Shi L, Liang H, Ding G, Xu L. Urban-rural disparities in health care utilization among Chinese adults from 1993 to 2011. BMC Health Serv Res. 2018;18(1):102. https://doi.org/10.1186/s12913-018-2905-4
  31. Tang T, Liu F, Lu X, Huang Q. Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China. Journal of International Medical Research. 2017;45(2):816-822. https://doi.org/10.1177/0300060517698618
  32. Pinto MF, Steffen R, Entringer A, Costa A, Trajman A. Budget impact of the incorporation of GeneXpert MTB/RIF for diagnosis of pulmonary tuberculosis from the perspective of the Brazilian Unified National Health System, Brazil, 2013-2017. Cadernos De Saude Publica. 2017;33(9):e 00214515. https://doi.org/10.1590/0102-311X00214515
  33. Reis S, Harter J, Lima LM, Vieira D, Palha P, Gonzales R. Geographical and organizational aspects of primary health care services in detecting tuberculosis cases in Pelotas, Rio Grande do Sul, Brazil, 2012. Epidemiol Serv Saude. 2017;26(1):141-148. https://doi.org/10.5123/S1679-49742017000100015
  34. Personalised medicine in the UK. The Lancet. 2017;391:10115. https://doi.org/10.1016/S0140-6736(17)33261-0
  35. Aldridge RW, Zenner D, White PJ, et al. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. The Lancet. 2016;388:2510-2518. https://doi.org/10.1016/S0140-6736(16)31008-X
  36. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A. Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. European Respiratory Journal. 2011;37:1175-1182. https://doi.org/10.1183/09031936.00105810
  37. Aldridge RW, Zenner D, White PJ, et al. Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study. The Lancet. 2016;16(8):962-970. https://doi.org/10.1016/S1473-3099(16)00072-4
  38. Harris MF. Integration of refugees into routine primary care in NSW, Australia. Public Health Res Pract. 2018;28(1):2811802. https://doi.org/10.17061/phrp2811802
  39. Williams E, Cheng A, Lane GP, Guy SD. Delays in presentation and diagnosis of pulmonary tuberculosis: a retrospective study of a tertiary health service in Western Melbourne, 2011—2014. Internal Medicine Journal. 2018;48(2):184-193. https://doi.org/10.1111/imj.13551
  40. Shah NS, Flood-Bryzman A, Jeffries C, Scott J. Towards a Generation Free of Tuberculosis: TB disease and Infection in Individuals of College Age in the United States. Journal of American College Health. 2017;66(1):17-22. https://doi.org/10.1080/07448481.2017.1363765
  41. Anthony TF, Natalie LS, Andrew SA, Emily AK, Sourya S, Shama DA. Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis. The Lancet. 2017;2(7):323-330. https://doi.org/10.1016/S2468-2667(17)30119-6
  42. Puzyreva LV, Mordyk AV, Batisheva TL. Problems of the patient with tuberculosis and his family in the era of the economic crisis. Nauka i innovacii v medicine. 2017;2(6):52-55. (In Russ.)
  43. Zubova NA, Cybikova EB, Punga VV, Sabgajda TP. Tuberculosis of the lungs in patients, revealed during periodic examinations and when contacting medical organizations. Tuberkulez i bolezni legkih. 2016;94(11):22-28. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-11-22-28
  44. Koreckaja N, Narkevich A. Benefits of active detection of pulmonary tuberculosis. Vrach. 2013;7:87-88. (In Russ.)
  45. Borodulina EA, Yakovleva EV. Disseminated pulmonary tuberculosis: modern aspects. Nauka i innovatsii v meditsine. 2017;2(6):39-43. (In Russ.)
  46. Astaf’ev VA, Savilov ED, Zhdanova SN, Ogarkov OB, Zarbuev AN, Kichigina EL. Tuberculosis in the main social risk groups. Sibirskij medicinskij zhurnal. 2014;129(6):114-117. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.